KRYS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.06

Margin Of Safety %

-16

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.36

EPS Last/This Y

1.3

EPS This/Next Y

1.7

Price

299.26

Target Price

330.56

Analyst Recom

1.17

Performance Q

9.05

Upside

-12.6%

Beta

0.51

Ticker: KRYS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	KRYS	267.9	0.69	0.05	5137
2026-04-24	KRYS	272.1	0.69	0.64	5141
2026-04-27	KRYS	272.87	0.69	0.08	5133
2026-04-28	KRYS	269.23	0.69	1.20	5139
2026-04-29	KRYS	259.64	0.69	0.35	5146
2026-04-30	KRYS	262.2	0.69	0.40	5159
2026-05-01	KRYS	265.66	0.69	7.64	5164
2026-05-04	KRYS	285.06	0.79	4.98	5517
2026-05-05	KRYS	284.29	0.74	0.11	5407
2026-05-06	KRYS	288.99	0.65	0.07	5855
2026-05-07	KRYS	296.95	0.64	0.24	5941
2026-05-08	KRYS	305.99	0.63	0.38	6090
2026-05-11	KRYS	313.07	0.64	0.17	6278
2026-05-12	KRYS	309.85	0.62	0.04	6452
2026-05-13	KRYS	312.34	0.62	0.49	6496
2026-05-14	KRYS	316.49	0.63	0.00	6655
2026-05-15	KRYS	306.46	0.58	0.26	7030
2026-05-18	KRYS	291.74	0.16	0.88	3031
2026-05-19	KRYS	293.66	0.19	0.26	3116
2026-05-20	KRYS	301.97	0.19	0.25	3122
2026-05-21	KRYS	304.38	0.19	5.00	3148
2026-05-22	KRYS	299.28	0.23	0.11	3249
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	KRYS	267.93	20.5	46.1	7.74
2026-04-24	KRYS	272.52	20.5	57.5	7.74
2026-04-27	KRYS	272.65	18.2	53.3	7.57
2026-04-28	KRYS	269.52	18.2	50.4	7.57
2026-04-30	KRYS	262.35	18.2	55.7	7.57
2026-05-01	KRYS	265.85	18.2	56.5	7.57
2026-05-04	KRYS	286.58	18.2	71.7	7.57
2026-05-05	KRYS	284.52	18.2	51.1	7.57
2026-05-06	KRYS	288.80	18.2	56.7	7.57
2026-05-07	KRYS	296.57	34.3	48.0	7.76
2026-05-08	KRYS	305.83	34.3	49.2	7.76
2026-05-11	KRYS	312.88	34.0	47.1	7.69
2026-05-12	KRYS	309.76	50.5	39.2	8.51
2026-05-13	KRYS	312.61	50.5	43.4	8.51
2026-05-14	KRYS	316.20	50.5	44.4	8.51
2026-05-15	KRYS	306.47	50.5	33.7	8.51
2026-05-18	KRYS	291.24	50.5	29.7	8.38
2026-05-19	KRYS	293.30	50.5	43.3	8.38
2026-05-20	KRYS	302.04	50.5	48.5	8.38
2026-05-21	KRYS	304.29	50.5	43.4	8.38
2026-05-22	KRYS	299.26	50.5	37.5	8.38
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	KRYS	-6.08	-1.32	12.30
2026-04-24	KRYS	-6.08	-1.32	12.30
2026-04-27	KRYS	-6.08	-1.59	11.39
2026-04-28	KRYS	-6.19	-1.59	11.39
2026-04-29	KRYS	-6.19	-1.59	11.39
2026-04-30	KRYS	-6.19	-1.59	11.39
2026-05-01	KRYS	-6.19	-1.59	11.39
2026-05-04	KRYS	-6.19	-1.34	11.39
2026-05-05	KRYS	-6.19	-1.34	11.39
2026-05-06	KRYS	-6.19	-1.34	11.39
2026-05-07	KRYS	-6.18	-1.34	11.37
2026-05-08	KRYS	-6.18	-1.34	11.37
2026-05-11	KRYS	-6.18	-1.47	11.37
2026-05-12	KRYS	-6.18	-1.47	12.08
2026-05-13	KRYS	-6.18	-1.47	12.08
2026-05-14	KRYS	-6.18	-1.47	12.08
2026-05-15	KRYS	-6.18	-1.47	12.08
2026-05-18	KRYS	-6.18	-1.99	12.06
2026-05-19	KRYS	-6.24	-1.99	12.06
2026-05-20	KRYS	-6.24	-1.99	12.06
2026-05-21	KRYS	-6.24	-1.99	12.06
2026-05-22	KRYS	-6.24	-1.99	12.06
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.83

Avg. EPS Est. Current Quarter

1.94

Avg. EPS Est. Next Quarter

2.19

Insider Transactions

-6.24

Institutional Transactions

-1.99

Beta

0.51

Average Sales Estimate Current Quarter

125

Average Sales Estimate Next Quarter

137

Fair Value

252.73

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

6.3

Max Drawdown 5-Year %

-44.5

Target Price

330.56

P/E

40.03

Forward P/E

30.84

PEG

1.33

P/S

21.15

P/B

6.9

P/Free Cash Flow

37.19

EPS

7.48

Average EPS Est. Cur. Y

8.38

EPS Next Y. (Est.)

10.08

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

53.92

Relative Volume

0.57

Return on Equity vs Sector %

-9.4

Return on Equity vs Industry %

6.2

EPS 1 7Days Diff

EPS 1 30Days Diff

0.64

EBIT Estimation

37.5

◆ KRYS Healthcare

$299.45

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

11/15

Valuation

9/20

TP/AR

6/10

Options

8/10

RSI

56.6

Range 1M

69.5%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

5/25

Growth

22/30

Estimates

9/20

Inst/Vol

2/15

Options

8/10

EPS Yr

13.3%

EPS NY

25.3%

52W%

89.5%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +6.3% upside

Quality

21/30

Valuation

4/30

Growth

19/25

Stability

7/10

LT Trend

1/5

Upside

+6.3%

Quality

MoS

-16%

Krystal Biotech, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 295

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

KRYS

Latest News

—

Caricamento notizie per KRYS…

stock quote shares KRYS – Krystal Biotech, Inc. Stock Price stock today

news today KRYS – Krystal Biotech, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch KRYS – Krystal Biotech, Inc. yahoo finance google finance

stock history KRYS – Krystal Biotech, Inc. invest stock market

stock prices KRYS premarket after hours

ticker KRYS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: KRYS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y